Louis Lehot Comments on Startup Founders Using Record-High Valuations to Cash Out Earlier
30 September 2023
Foley Partner Louis Lehot was quoted in The Information article titled, “Startup Founders Use Record-High Valuations to Cash Out Earlier.” The article discusses the past year’s funding boom and how founders of young companies are increasingly selling millions of dollars of shares in the earliest stages of the capital-raising process.
Lehot commented, “It used to be that founders would ask for [secondary sales]. Now, venture capitalists are coming out of the gate with it. Half of Series A and B deals now have some secondary component for founders.”
Read the full article here (subscription required). Lehot’s quote also appeared in the Grant’s Interest Rate Observer article titled “Early Risers” here.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”